HUP0004432A3 - Thermodynamically stable form of (r)-3-[[(4-fluorophenyl)sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban) and pharmaceutical composition containing it - Google Patents
Thermodynamically stable form of (r)-3-[[(4-fluorophenyl)sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban) and pharmaceutical composition containing itInfo
- Publication number
- HUP0004432A3 HUP0004432A3 HU0004432A HUP0004432A HUP0004432A3 HU P0004432 A3 HUP0004432 A3 HU P0004432A3 HU 0004432 A HU0004432 A HU 0004432A HU P0004432 A HUP0004432 A HU P0004432A HU P0004432 A3 HUP0004432 A3 HU P0004432A3
- Authority
- HU
- Hungary
- Prior art keywords
- ramatroban
- sulphonyl
- carbazole
- fluorophenyl
- tetrahydro
- Prior art date
Links
- LDXDSHIEDAPSSA-OAHLLOKOSA-N Ramatroban Chemical compound N([C@@H]1CCC=2N(C3=CC=CC=C3C=2C1)CCC(=O)O)S(=O)(=O)C1=CC=C(F)C=C1 LDXDSHIEDAPSSA-OAHLLOKOSA-N 0.000 title 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229950004496 ramatroban Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19757983A DE19757983A1 (de) | 1997-12-24 | 1997-12-24 | Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban) |
PCT/JP1998/005844 WO1999033803A1 (en) | 1997-12-24 | 1998-12-24 | Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino] -1,2,3,4- tetrahydro -9h-carbazole -9-propanoic acid (ramatroban) |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0004432A2 HUP0004432A2 (hu) | 2001-06-28 |
HUP0004432A3 true HUP0004432A3 (en) | 2002-10-28 |
Family
ID=7853457
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0004432A HUP0004432A3 (en) | 1997-12-24 | 1998-12-24 | Thermodynamically stable form of (r)-3-[[(4-fluorophenyl)sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban) and pharmaceutical composition containing it |
Country Status (37)
Country | Link |
---|---|
US (1) | US6362214B1 (hu) |
EP (1) | EP1051398B1 (hu) |
JP (2) | JP3817668B2 (hu) |
KR (1) | KR100586350B1 (hu) |
CN (1) | CN1140510C (hu) |
AR (1) | AR013803A1 (hu) |
AT (1) | ATE263152T1 (hu) |
AU (1) | AU744242B2 (hu) |
BG (1) | BG65024B1 (hu) |
BR (1) | BR9814496A (hu) |
CA (1) | CA2313230A1 (hu) |
CO (1) | CO4970800A1 (hu) |
DE (2) | DE19757983A1 (hu) |
DK (1) | DK1051398T3 (hu) |
ES (1) | ES2218874T3 (hu) |
GT (1) | GT199800198A (hu) |
HK (1) | HK1034517A1 (hu) |
HN (1) | HN1998000186A (hu) |
HU (1) | HUP0004432A3 (hu) |
ID (1) | ID25446A (hu) |
IL (1) | IL136278A (hu) |
IN (1) | IN192932B (hu) |
MY (1) | MY116312A (hu) |
NO (1) | NO316618B1 (hu) |
NZ (1) | NZ504741A (hu) |
PE (1) | PE20000115A1 (hu) |
PL (1) | PL341359A1 (hu) |
PT (1) | PT1051398E (hu) |
RU (1) | RU2220137C2 (hu) |
SI (1) | SI1051398T1 (hu) |
SK (1) | SK285109B6 (hu) |
TR (1) | TR200001936T2 (hu) |
TW (1) | TW552258B (hu) |
UA (1) | UA66832C2 (hu) |
UY (2) | UY25324A1 (hu) |
WO (1) | WO1999033803A1 (hu) |
ZA (1) | ZA9811817B (hu) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2395120T3 (es) * | 2006-12-20 | 2013-02-08 | Cardoz Ab | Combinación de pemirolast y ramotrobán para su uso en el tratamiento de transtornos inflamatorios |
CA2675520A1 (en) * | 2007-01-16 | 2008-07-24 | Cardoz Ab | New combination for use in the treatment of inflammatory disorders |
WO2009007674A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast |
CN101434571B (zh) * | 2007-11-13 | 2012-05-30 | 杭州容立医药科技有限公司 | 环烷并[1,2-b]吲哚磺酰胺、其异构体或其盐的合成方法 |
WO2011115069A1 (ja) * | 2010-03-19 | 2011-09-22 | 第一三共株式会社 | 結晶の網羅的探索 |
CN103054857A (zh) * | 2012-12-30 | 2013-04-24 | 北京阜康仁生物制药科技有限公司 | 一种以雷马曲班为活性成分的固体制剂 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1015711B (zh) | 1986-02-21 | 1992-03-04 | 拜尔公司 | 制备环烷并[1,2-b]吲哚-磺酰胺类化合物的方法 |
DE3631824A1 (de) | 1986-02-21 | 1988-03-31 | Bayer Ag | Cycloalkano(1.2-b)indol-sulfonamide |
DE19506739A1 (de) | 1995-02-27 | 1996-08-29 | Bayer Ag | [3-Amino]-tetrahydrocarbazol-propansäureester |
-
1997
- 1997-12-24 DE DE19757983A patent/DE19757983A1/de not_active Withdrawn
-
1998
- 1998-12-09 HN HN1998000186A patent/HN1998000186A/es unknown
- 1998-12-11 AR ARP980106318A patent/AR013803A1/es unknown
- 1998-12-15 GT GT199800198A patent/GT199800198A/es unknown
- 1998-12-22 MY MYPI98005837A patent/MY116312A/en unknown
- 1998-12-22 PE PE1998001272A patent/PE20000115A1/es not_active Application Discontinuation
- 1998-12-23 CO CO98076459A patent/CO4970800A1/es unknown
- 1998-12-23 UY UY25324A patent/UY25324A1/es not_active IP Right Cessation
- 1998-12-23 ZA ZA9811817A patent/ZA9811817B/xx unknown
- 1998-12-23 TW TW087121479A patent/TW552258B/zh not_active IP Right Cessation
- 1998-12-24 AU AU16874/99A patent/AU744242B2/en not_active Ceased
- 1998-12-24 UA UA2000074335A patent/UA66832C2/uk unknown
- 1998-12-24 BR BR9814496-0A patent/BR9814496A/pt not_active Application Discontinuation
- 1998-12-24 DK DK98961506T patent/DK1051398T3/da active
- 1998-12-24 HU HU0004432A patent/HUP0004432A3/hu unknown
- 1998-12-24 AT AT98961506T patent/ATE263152T1/de not_active IP Right Cessation
- 1998-12-24 CA CA002313230A patent/CA2313230A1/en not_active Abandoned
- 1998-12-24 ES ES98961506T patent/ES2218874T3/es not_active Expired - Lifetime
- 1998-12-24 US US09/582,250 patent/US6362214B1/en not_active Expired - Fee Related
- 1998-12-24 TR TR2000/01936T patent/TR200001936T2/xx unknown
- 1998-12-24 ID IDW20001226A patent/ID25446A/id unknown
- 1998-12-24 IN IN43MU2000 patent/IN192932B/en unknown
- 1998-12-24 SK SK975-2000A patent/SK285109B6/sk unknown
- 1998-12-24 RU RU2000119741/04A patent/RU2220137C2/ru not_active IP Right Cessation
- 1998-12-24 NZ NZ504741A patent/NZ504741A/xx unknown
- 1998-12-24 PL PL98341359A patent/PL341359A1/xx not_active Application Discontinuation
- 1998-12-24 KR KR1020007007031A patent/KR100586350B1/ko not_active IP Right Cessation
- 1998-12-24 WO PCT/JP1998/005844 patent/WO1999033803A1/en not_active Application Discontinuation
- 1998-12-24 SI SI9830656T patent/SI1051398T1/xx unknown
- 1998-12-24 DE DE69822882T patent/DE69822882T2/de not_active Expired - Fee Related
- 1998-12-24 CN CNB98812405XA patent/CN1140510C/zh not_active Expired - Fee Related
- 1998-12-24 PT PT98961506T patent/PT1051398E/pt unknown
- 1998-12-24 EP EP98961506A patent/EP1051398B1/en not_active Expired - Lifetime
- 1998-12-24 IL IL13627898A patent/IL136278A/xx not_active IP Right Cessation
- 1998-12-24 JP JP2000526487A patent/JP3817668B2/ja not_active Expired - Lifetime
-
1999
- 1999-06-18 UY UY25575A patent/UY25575A1/es unknown
-
2000
- 2000-06-21 NO NO20003217A patent/NO316618B1/no unknown
- 2000-06-23 BG BG104554A patent/BG65024B1/bg unknown
-
2001
- 2001-07-27 HK HK01105260A patent/HK1034517A1/xx not_active IP Right Cessation
-
2005
- 2005-11-25 JP JP2005340586A patent/JP4411269B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA9811759B (en) | Novel indole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them. | |
HUP9701554D0 (en) | Pharmaceutical composition containing plazma proteins | |
AU3455297A (en) | Pharmaceutical composition containing acid addition salt of basic drug | |
HK1025904A1 (en) | Pharmaceutical composition for combination of piperidinoalkanol-decongestant | |
HUP0003844A3 (en) | Novel spiroazabicyclic heterocyclic compounds, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP9800813A3 (en) | Lactam-containing hydroxamic acid derivatives, their preparation and pharmaceutical compositions containing them | |
HUP0100280A3 (en) | Pyrrolo-, thieno-, furano- and pyrazolo- [3,4d]-pyridazinones, process for their preparation and pharmaceutical compositions containing them | |
HUP0001652A3 (en) | Oxadiazole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them | |
HUP9801045A3 (en) | Sulfonyl-amino-carboxylic acid derivatives, use thereof, pharmaceutical compositions containing them and process for their preparation | |
HK1025744A1 (en) | Pharmaceutical formulation of omeprazole | |
HUP9801044A3 (en) | Sulfonylamino-carboxylic acid derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0002830A3 (en) | Indole and 2,3-dihydroindole derivatives, their preparation, use, and pharmaceutical compositions containing them | |
HUP0003198A2 (en) | Thermodynamically stable modification of 1-(4-carbazoly-loxy)-3-[2-(2-(methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it | |
HUP0000960A3 (en) | Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same | |
HUP0004345A3 (en) | Novel oral pharmaceutical compositions containing from carvedilol | |
IL114673A (en) | Pharmaceutical compositions containing protein for oral administration | |
HUP0004432A3 (en) | Thermodynamically stable form of (r)-3-[[(4-fluorophenyl)sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban) and pharmaceutical composition containing it | |
AU3953197A (en) | Catechol amino acid derivatives and pharmaceutical compositions containing them | |
HK1055947A1 (en) | Novel branched substituted amino derivatives of 3-amino-1-phenyl-1H-Ä1,2,4Ütriazol, methods for producing them and pharmaceutical compositions containing them | |
AU1930097A (en) | Slow-release pharmaceutical formulations containing mizolastin | |
HUP0001873A3 (en) | Amidino-1,4-benzoxazepine derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
IL133826A0 (en) | Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino] methyl]amino]benzonitrile and pharmaceutical compositions containing the same | |
HUP0003104A3 (en) | Amino-spiropiperidin-quinazoline derivatives, their use, process for their preparation and pharmaceutical compositions containing them | |
HUP0001183A3 (en) | Pyrrolothiazine and pyrrolothiazepine derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP9800277A3 (en) | N-(1,2,3,4-tetrahydro-naphthyl- and -quinolyl)sulfonamide derivatives, their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing them |